Australia's largest stock trading and investment forum Australia's #1 stock forum

1AD

Click for more information

2.70%

1.8¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-122

First 122 Last

Share
Profile

Follow
asx11

3,862 Posts.

413

24/04/24

21:50

Post #: 73506250
Share

Originally posted by debono: ↑

Fridays below. When subscription runs out most will dump. It has gone from $99 pm to $349 pm. Not enough value so they will close down most likely.

Unfortunately, while we have tried to maintain the lowest possible prices since our openining in 2018, seeing no price increase since then, has left us vulnerable to an excessive price hike by a critical supplier of our data.

To be able to continue our website we must increase our price to $349 for all our members going forward.

No one will be charged this without first accepting, however, if enough people don't continue with it, we will innevtably close the website.

We appreciate everyone who has been with us for this whole journey and are sad to see it may come to an end. We do not like this happening, but we have no choice.

We hope you can understand our position and continue to be part of our journey.

If you are okay to continue with the subscription at this new price, please reply to this email with your acceptance, otherwise your subscription will finish once your anniversary date comes up.

Your next anniversary date will be on 2024-05-04.

View attachment 6127670

Expand

Thanks. So FNZ would've been the 2,500,000 million order that has only been partially filled for now.

1AD Price at posting: 2.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 5 more messages in this thread...

First 122 Last

Add 1AD (ASX) to my watchlist

(20min delay)
Last 1.8¢		Change -0.001(2.70%)		Mkt cap ! $10.91M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.8¢	$74	4.087K

Buyers (Bids)

No.	Vol.	Price($)
4	70421	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	197631	1

View Market Depth

No.	Vol.	Price($)
4	70421	0.018
2	1058823	0.017
7	968104	0.016
4	1659994	0.015
1	75000	0.014

Price($)	Vol.	No.
0.019	197631	1
0.020	250000	1
0.021	372500	2
0.022	500000	1
0.023	17643	1

Last trade - 13.40pm 07/10/2024 (20 minute delay)

1AD (ASX) Chart